Lymphatic transport of drugs after oral administration is an important physiological process in highly lipophilic compounds, such as cannabidiol (CBD). The majority of lymphatic transport studies have been historically conducted in anesthetized rats. However, this animal model differs significantly from the humans regarding both anatomical and physiological features. The aim of this study was therefore to develop a novel animal model using pigs and to provide an interspecies comparison for the lymphatic transport of CBD. The thoracic lymph duct was cannulated via thoracotomy in three pigs and lymph and blood were sampled from conscious animals to assess the lymphatic transport parameters and basic pharmacokinetic parameters of CBD administered in two distinct drug formulations (sesame oil-based solution and nanoemulsion) using a two-period cross-over study design. The mean ± SD oral bioavailability (F) was 6.1 ± 0.9% for the oil solution and 9.2 ± 6.6% for the nanoemulsion. The relative bioavailability via lymph (FRL), i.e. the percentage of the systemically available drug that has been transported through the mesenteric lymph, was 20 ± 10% and 11 ± 13%, respectively. Whereas the FRL for the oil solution was 2.3-fold lower in pigs compared to rats, the FRL for the nanoemulsion was almost identical for both species. In conclusion, the lymphatic transport of CBD plays an important role after its oral administration. The particular parameters differed significantly between the rodent and higher non-rodent species. The use of higher species models is therefore warranted for the lymphatic transport assessment in settings close to humans.

Children's Cardiac Center 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Deparment of Analytical Chemistry Faculty of Science Charles University Prague Prague Czech Republic

Deparment of Cardiac Surgery Masaryk Hospital in Ústí nad Labem Ústí nad Labem Czech Republic

Deparment of Cardiovascular Surgery 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Chemical Engineering Faculty of Chemical Engineering University of Chemistry and Technology Prague Czech Republic

Institute of Pharmacology 1st Faculty of Medicine General University Hospital Prague Charles University Prague Czech Republic

Institute of Physiology 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Akkaya MR. 2018. Prediction of fatty acid composition of sunflower seeds by near-infrared reflectance spectroscopy. J Food Sci Technol. 55:2318–2325. 10.1007/s13197-018-3150-x PubMed DOI PMC

Blomstrand R, Forsgren L. 1968. Vitamin K1-3H in man. Its intestinal absorption and transport in the thoracic duct lymph. Int Z Vitaminforsch. 38:45–64. PubMed

Bollman JL, Cain JC, Grindlay JH. 1948. Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat. J Lab Clin Med. 33:1349–1352. PubMed

Caliph SM, Charman WN, Porter CJ. 2000. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci. 89:1073–1084. 10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V PubMed DOI

Chanoit G, Ferré PJ, Lefebvre HP. 2007. Chronic lymphatico-venous bypass: surgical technique and aftercare in a porcine model. Interact Cardiovasc Thorac Surg. 6:705–707. 10.1510/icvts.2007.157867 PubMed DOI

Cope C. 1995. Percutaneous thoracic-duct cannulation - feasibility study in swine. J Vasc Interv Radiol. 6:559–564. 10.1016/S1051-0443(95)71134-4 PubMed DOI

Court MH, et al. 2024. Cannabidiol and cannabidiolic acid: preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein. J Vet Pharmacol Ther. 47:1–13. 10.1111/jvp.13403 PubMed DOI

Dahan A, Mendelman A, Amsili S, Ezov N, Hoffman A. 2007. The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs: comparison between anesthetized and freely moving conscious rat models. Eur J Pharm Sci. 32:367–374. 10.1016/j.ejps.2007.09.005 PubMed DOI

Dalgaard L. 2015. Comparison of minipig, dog, monkey and human drug metabolism and disposition. J Pharmacol Tox Met. 74:80–92. 10.1016/j.vascn.2014.12.005 PubMed DOI

EMA . 2022. ICH guideline M10 on bioanalytical method validation and study sample analysis.

Forth W, Furukawa E, Rummel W. 1969. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats]. Naunyn Schmiedebergs Arch Pharmakol. 264:406–419. PubMed

Higashiyama H, et al. 2018. Anatomy and development of the extrahepatic biliary system in mouse and rat: a perspective on the evolutionary loss of the gallbladder. J Anat. 232:134–145. 10.1111/joa.12707 PubMed DOI PMC

Horst HJ, et al. 1976. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr. 54:875–879. 10.1007/BF01483589 PubMed DOI

Jelinek P, et al. 2022. Application of oil-in-water cannabidiol emulsion for the treatment of rheumatoid arthritis. Cannabis Cannabinoid. 9(1):147–159. 10.1089/can.2022.0176 PubMed DOI PMC

Jensen LT, Olesen HP, Risteli J, Lorenzen I. 1990. External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph. Lab Anim Sci. 40:620–624. PubMed

Khoo SM, Edwards GA, Porter CJH, Charman WN. 2001. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. J Pharm Sci. 90:1599–1607. 10.1002/jps.1110 PubMed DOI

Khoo SM, Shackleford DM, Porter CJH, Edwards GA, Charman WN. 2003. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs. Pharm Res. 20:1460–1465. 10.1023/A:1025718513246 PubMed DOI

Lui CY, et al. 1986. Comparison of gastrointestinal Ph in dogs and humans - implications on the use of the beagle dog as a model for oral absorption in humans. J Pharm Sci-US. 75:271–274. 10.1002/jps.2600750313 PubMed DOI

Mendenhall HV, Horvath C, Piechowiak M. 1996. An external thoracic duct venous shunt to allow for long term collection of lymph and blood in the conscious pig. Adv Swine Biomed Res. 1,2:621–627. 10.1007/978-1-4615-5885-9_17 DOI

Ohlsson A, et al. 1986. Single-dose kinetics of deuterium-labeled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass. 13:77–83. 10.1002/bms.1200130206 PubMed DOI

Porter CJH, Trevaskis NL, Charman WN. 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 6:231–248. 10.1038/nrd2197 PubMed DOI

Pozniak J, Ryšánek P, Smrčka D.. 2024. Ivacaftor pharmacokinetics and lymphatic transport after enteral administration in rats. Front Pharmacol. 15. 10.3389/fphar.2024.1331637 PubMed DOI PMC

Qian LX, Beers JL, Jackson KD, Zhou Z. 2024. CBD and THC in special populations: pharmacokinetics and drug-drug interactions. Pharmaceutics. 16:484. 10.3390/pharmaceutics16040484 PubMed DOI PMC

Rajpal SG, Kirkpatrick JR. 1972. Creation of a thoracic-duct fistula-improved technique. J Surg Res. 13:260–261. 10.1016/0022-4804(72)90074-1 PubMed DOI

Ryšánek P, Grus T, Šíma M, Slanař O. 2020. Lymphatic transport of drugs after intestinal absorption: impact of drug formulation and physicochemical properties. Pharm Res. 37:166. 10.1007/s11095-020-02858-0 PubMed DOI

Rysanek P, et al. 2021. Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs. Brit J Pharmacol. 178:4663–4674. 10.1111/bph.15644 PubMed DOI

Rysanek P, et al. 2025. Effect of quantitative structural properties and drug formulation in four cannabinoids (cannabidiol, cannabigerol, cannabichromene, and cannabinol) on their lymphatic transport after enteral administration in rats. Mol Pharm. 22:4544–4555. 10.1021/acs.molpharmaceut.4c01357 PubMed DOI PMC

Salamunova P, et al. 2023. Serum and lymph pharmacokinetics of nilotinib delivered by yeast glucan particles per os. Int J Pharm. 634:122627. 10.1016/j.ijpharm.2023.122627 PubMed DOI

Shackleford DM, et al. 2003. Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J Pharmacol Exp Ther. 306:925–933. 10.1124/jpet.103.052522 PubMed DOI

Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. 2019. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects (vol 32, pg 1053, 2018). CNS Drugs. 33:397–397. 10.1007/s40263-019-00617-3 PubMed DOI PMC

Trevaskis NL, Hu L, Caliph SM, Han S, Porter C. 2015. The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transport. J Vis Exp. 52389. 10.3791/52389-v PubMed DOI PMC

Trevaskis NL, et al. 2013. A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport. Pharm Res-Dordr. 30:3254–3270. 10.1007/s11095-013-1000-0 PubMed DOI PMC

Trevaskis NL, et al. 2009. Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism. Pharm Res-Dordr. 26:1486–1495. 10.1007/s11095-009-9860-z PubMed DOI

Trevaskis NL, et al. 2020. Intestinal lymph flow, and lipid and drug transport scale allometrically from pre-clinical species to humans. Front Physiol. 11:458. 10.3389/fphys.2020.00458 PubMed DOI PMC

White DG, Story MJ, Barnwell SG. 1991. An experimental animal model for studying the effects of a novel lymphatic drug delivery system for propranolol. Int J Pharm. 69:169–174. 10.1016/0378-5173(91)90221-9 DOI

White KL, et al. 2009. Lymphatic transport of methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU. J Pharmacol Exp Ther. 331:700–709. 10.1124/jpet.109.154542 PubMed DOI

WHO . 2018. WHO expert committee on drug dependence (Fourtieth report).

Yen HH, Davies HMS. 2016. Techniques for thoracic duct cannulation without thoracotomy in piglets. BMC Vet Res. 12:204. 10.1186/s12917-016-0808-3 PubMed DOI PMC

Zgair A, et al. 2016. Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Am J Transl Res. 8:3448–3459. PubMed PMC

Zhang Y, Huo MR, Zhou JP, Xie S. 2010. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Meth Prog Biol. 99:306–314. 10.1016/j.cmpb.2010.01.007 PubMed DOI